The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The L-Histidine monohydrochloride Drug Master File in Japan (L-Histidine monohydrochloride JDMF) empowers L-Histidine monohydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the L-Histidine monohydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of L-Histidine monohydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of L-Histidine monohydrochloride suppliers with JDMF on PharmaCompass.